Surgical Robot Systems Market Size, Share & Trends Analysis Report By Component (Surgical Robot, Surgical Robotic Accessories, Surgical Robotic Services), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Surgical Robot Systems Market Trends

The global surgical robot systems market size was estimated at USD 10.21 billion in 2023 and is projected to grow at a CAGR of 12.4% from 2024 to 2030. Surgical robot systems revolutionize surgery, driven by significant factors such as technological progress, the rising preference for minimally invasive procedures, improved outcomes, greater precision, and reduced human errors in operations. This development is a major advancement in medical technology, combining innovation with a commitment to enhancing the safety and efficacy of surgical operations.In July 2023, a study featured in the Journal of Hematology & Oncology revealed that basic medical nanorobots could advance to become more complex, performing various medical tasks directly in the bloodstream.

Advancements in technology have played a significant role in driving the adoption of surgical robot systems. Integrating technologies such as artificial intelligence, machine learning, haptic feedback, and augmented reality has enhanced the capabilities of robotic surgical systems. For instance, in April 2024, spaceMIRA, a surgical robot developed by Virtual Incision and the University of Nebraska, was sent to the ISS for remote testing. This space-focused version of Virtual Incision's miniaturized robotic-assisted surgery system, MIRA, is designed for compactness and convenience. The device's modifications allowed long-distance remote surgery, demonstrating significant advancements in medical technology.

The rising demand for minimally invasive procedures has been a key driver for adopting surgical robot systems. Minimally invasive surgeries offer patients benefits such as shorter hospital stays, faster recovery times, lower risk of complications than traditional open surgeries, and reduced pain. Robotic systems enable surgeons to perform complex procedures through small incisions with greater precision and control. In July 2024, AcuSurgical completed its first clinical study with the Luca surgical robot for vitrectomy procedures. The study targeted the treatment of retinal diseases, affecting over 300 million worldwide, requiring precision only achievable by highly trained surgeons. 

The ability to improve surgical outcomes for patients is one of the key drivers for surgical robot systems. Robotic-assisted surgery allows for greater accuracy and precision during procedures, leading to reduced blood loss. Robotic surgery can result in better clinical outcomes and higher patient satisfaction compared to traditional methods. For instance, in December 2023, a study published in Cureus stated that the benefits of surgical robot systems include improved patient outcomes, reduced complications, faster recovery time, cost-effectiveness, and enhanced surgeon experiences. In June 2024, Sovato announced the successful completion of distant robotic-assisted surgeries using the company’s platform, highlighting surgeon confidence and showcasing a scalable solution for remote surgical procedures.

Surgical robot systems’ potential to reduce human errors in the operating room is another significant driver for the market growth. Robotic systems offer steady hands and precise movements that can minimize the risk of human error during delicate surgical procedures. By providing surgeons with enhanced visualization and dexterity, robotic platforms help mitigate factors such as hand tremors or fatigue that could affect procedural accuracy. In April 2024, an article in the Advanced Intelligent Systems Influence Series reported that a significant majority of 73.8% of 244 trainees, expressed a strong interest in having more opportunities for robotic surgery training. This is due to the growing belief in its critical importance for the future of surgical care .

Component Insights

Based on component, the surgical robotic accessories segment led the market with the largest revenue share of 46.61% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. The market includes various supplementary parts and devices essential for the successful operation of surgical robots in medical procedures. These additional elements enhance accuracy, better visualization, and support the smooth execution of surgeries. Robotic accessories encompass end-effectors, robotic arms, wristed tools, surgery cameras, control panels, and specialized instruments. In September 2022, eCential Robotics received FDA clearance for its unified robotic platform, featuring 3D imaging, navigation, and a robotic arm, facilitating its expansion into the U.S. market. 

The surgical robotic services segment is expected to grow at a significant CAGR over the forecast period. The use of surgical robots became increasingly common in surgeries involving the liver, gastrointestinal tract, pancreas, and other areas of the abdomen. Their ability to perform complex general surgical procedures with high precision made them exceptionally valuable. These robots require timely training & implementation services and regular maintenance services to ensure their precise and accurate performance. In May 2023, THINK Surgical partnered with Waldemar Link GmbH & Co. KG to add the LinkSymphoKnee System to its TMINI robotic system's ID-HUB, enhancing implant options for more precise orthopedic surgeries. The market's growth is propelled by rising investments and funding from governments worldwide.

Application Insights

Based on application, the orthopedic segment led the market with the significant revenue share of 19.60% in 2023. The increasing prevalence of orthopedic disorders such as osteoarthritis, rheumatoid arthritis, and osteoporosis primarily drives the orthopedics segment. In August 2023, a study in the Lancet forecasts that nearly 1 billion individuals will suffer from osteoarthritis, arthritis, by 2050. It stated that osteoarthritis affects 15% of those aged 30 and above. The rising geriatric population globally and the growing demand for minimally invasive surgeries, is fueling the adoption of surgical robots in orthopedic procedures. These robots offer greater precision, accuracy, and control during surgeries, leading to better patient outcomes and reduced recovery times. For instance, In June 2024, Zimmer Biomet formed an exclusive partnership with Think Surgical to distribute a specialized wireless robotic device for knee surgeries. This new product, is an adapted version of Think's robotic technology, supports implants from multiple providers.

The neurology segment is expected to grow at the fastest CAGR over the forecast period. The rise in neurological disorders such as Parkinson’s and epilepsy fuels the demand for advanced surgical robot systems in neurology aimed at improving precision and outcomes in neurosurgical procedures. The trend towards minimally invasive surgeries propels the development of neuro-specific robotic technology, offering greater accuracy and reducing complication risks in complex surgeries such as brain tumor removals. Enhanced by advancements in real-time imaging, these robotic systems provide critical visualization and navigation capabilities, marking significant progress in neurosurgical intervention methodologies. For instance, in January 2024, Brain Navi's NaoTrac robot used in its 100th neurosurgery. The company planned to seek FDA approval in the U.S. NaoTrac incorporates robotics, AI, and machine vision through its SMART technology for more efficient and minimally invasive surgeries.

End-use Insights

Based on end use, the inpatient segment led the market with the largest revenue share of 53.30% in 2023. The demand for surgical robots in hospitals is growing mainly due to the rising number of chronic diseases that require intricate surgeries, which results in hospital stays. This increase is primarily seen in cases of heart disease, cancer, and neurological conditions, thereby boosting the need for robotic-assisted surgical procedures in inpatient environments. Factors such as more precise surgeries, quicker patient recovery, and reduced time spent in hospitals drive hospitals to adopt these advanced systems to improve patient results and operational efficiency. In April 2024, Cheshire Medical Center, part of Dartmouth Health, acquired Intuitive Surgical's first robotic surgical platform, the da Vinci Xi. It enabled the center to conduct various minimally invasive surgeries annually. Initially, it would be utilized for general, bariatric, and gynecological surgeries such as gallbladder removal, hysterectomies, and sleeve gastrostomies.

The outpatient segment is expected to witness at the fastest CAGR over the forecast period. The growth in the outpatient sector for surgical robot systems is attributed to a movement towards ambulatory surgery centers (ASCs) and outpatient centers for more straightforward procedures that don't necessitate a stay in the hospital overnight. This movement is propelled by cost savings, convenience, and technological advancements that enable faster recovery and fewer complications after surgery. In May 2023, Moon Surgical secured USD 55.5 million in funding for its robotic surgical assistant. The company intends to initially roll out the product in the U.S., explicitly targeting ambulatory surgical centers and outpatient departments that frequently perform general or bariatric surgeries.

Regional Insights

North America dominated the surgical robot systems market with the revenue share of 49.9% in 2023. In North America, a key driver of the market growth is the high adoption rate of advanced medical technologies and robotics. The region boasts a well-established healthcare infrastructure and a strong focus on technological advancements, leading to a higher acceptance of robotic-assisted surgeries. In June 2024, Texas Health augmented its fleet of surgical robots to boost surgeons' precision, aiming to improve patient outcomes throughout the system. By June, Texas Health aimed to equip 12 hospitals with the da Vinci 5 robotic systems. In addition, the increasing prevalence of chronic diseases such as cancer and the growing demand for minimally invasive procedures drive the market growth in North America.

U.S. Surgical Robot Systems Market Trends

The surgical robot systems market in the U.S. is expected to grow at the fastest CAGR over the forecast period The U.S. stands out in the global market due to its robust research and development activities and substantial investments in healthcare innovation. With many top-tier hospitals and academic institutions collaborating on cutting-edge robotic surgery techniques, the U.S. remains at the forefront of technological advancements in this field. In July 2024, Microbot Medical disclosed a partnership with the Baptist Hospital of Miami for a clinical trial. This follows Institutional Review Board approval and the signing of a Clinical Trial Agreement. The trial involves Miami Cardiac & Vascular Institute, and Miami Cancer Institute featured Microbot's LIBERTY device under its Investigational Device Exemption.

Europe Surgical Robot Systems Market Trends

The surgical robot systems market in Europe was identified as a lucrative region in this industry.In Europe, a significant driver for the market growth is the increasing emphasis on precision medicine and personalized healthcare solutions. Countries such as Germany, France, and the UK invest heavily in healthcare digitization and automation to enhance patient outcomes and optimize surgical procedures. The region benefits from a rising geriatric population that requires complex surgeries, further propelling the demand for advanced robotic systems such as those offered by CMR Surgical with its Versius platform. Regulatory bodies, including CE marking, ensure high safety standards for robotic surgical devices in Europe, fostering market expansion.In February 2022, Medtronic and OLV Hospital Aalst in Belgium successfully conducted the first European clinical procedure using the Hugo robotic-assisted surgery system for a prostatectomy, with involvement from the ORSI Academy's CEO and founder.

Asia Pacific Surgical Robot Systems Market Trends

The surgical robot systems market in Asia Pacific is anticipated to witness at the fastest CAGR from 2024 to 2030.Asia Pacific’s market is driven by rising healthcare expenditure, improving access to advanced medical technologies, and a growing patient pool seeking quality healthcare services. Countries such as Japan, South Korea, and China are witnessing an uptick in robot-assisted surgeries due to their aging populations and increasing prevalence of chronic diseases. In March 2024, Nanomaterials published an article detailing how nanorobots maneuvered complex biological settings to identify and reach specific targets for medical interventions. These miniature machines penetrated cell membranes with external power and quickly delivered therapeutic agents, acting as both toxin scavengers and precise treatment vehicles at the cellular level. This innovation empowers nanorobots to act almost like tiny surgeons, adjusting cellular functions and metabolism for targeted therapies.

Key Surgical Robot Systems Company Insights

Key players operating in the global market are undertaking various initiatives to strengthen their market presence and increase the reach of their components and services. Strategies such as expansion activities and partnerships are playing a key role in propelling the market growth.

Recent Developments

• In June 2024, Asensus Surgical Inc., which specializes in developing augmented intelligence technology for intra-operative use in operating rooms, finalized a merger agreement with KARL STORZ Endoscopy-America Inc. This agreement aims to improve KARL STORZ's standing in the surgical robotics industry, particularly focusing on the advancement of the next-generation LUNA system by Asensus

• In June 2024, Moon Surgical's Maestro Robotic Surgery System received its second FDA clearance, designed to enhance soft tissue surgeries in the broad laparoscopy market. The system, notable for its adaptability and efficiency improvements, will see a limited release in the U.S. and Europe, with a broader launch planned for 2025

• In March 2024, Intuitive Surgical obtained FDA 510(k) clearance for its new multiport robotic system, da Vinci 5. This system advances the capabilities of the da Vinci Xi, previously used in over 7 million operations worldwide, setting a new standard for minimally invasive procedures

Surgical Robot Systems Market Report Scope

Global Surgical Robot Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global surgical robot systems market report based on component, application, end-use, and region:

• Component Outlook (Revenue, USD Million, 2018 - 2030)

  • Surgical Robot

  • Surgical Robotic Accessories

  • Surgical Robotic Services

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Orthopedics

  • Neurology

  • Gynecology

  • Urology

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Inpatient

  • Outpatient

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait